Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Xcessbio/GSK-J1, H3K27 Histone Demethylases UTX and JMJD3 Inhibitor -Xcessbio Biosciences Inc/2mg solid/M60062-2s188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Xcessbio/GSK-J1, H3K27 Histone Demethylases UTX and JMJD3 Inhibitor -Xcessbio Biosciences Inc/2mg solid/M60062-2s

Details
Product Information
Molecular Weight: 389.45
Formula:C22H23N5O2
Purity:≥98%
CAS#:1373422-53-7
Solubility:DMSO up to 100 mM
Chemical Name: 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid
Storage:Powder:4oC 1 year. DMSO:4oC3 month;-20oC 1 year.

Biological Activity:

GSK-J1 is the first selective and potent inhibitor of the H3K27 histone demethylases UTX and JMJD3. It has no activity against a panel of JMJ family demethylases and 100 protein kinases. H3K27 methylations play important roles in regulating gene expression through the polycomb-repressive complex (PRC1 or PRC2). This epigenetic mark can be demethylated by lysine demethylase (KDM) UTX and JMJD3, which play important roles in cellular differentiation, development and cancer. In relevant biological assays, GSK-J1 was shown to reduce lipopolysaccharide-induced pro-inflammatory cytokine production by human primary macrophages, a process that depends on both UTX and JMJD3. GSK-J1 represents a unique small molecule tool to allow selective pharmacological intervention across the JMJ family.

Although critical for in vitro binding, the highly polar carboxylate group of GSK-J1 restricts its cellular permeability. Therefore another compound, GSK-J4, was developed as a pro-drug, masking the polarity of the acid group of the GSK-J1, for cellular assays.

How to Use:

  • In vitro: GSK-J1 was used at 30-100 µM final concentration in vitro.
  • In vivo:n/a

Reference:

  • 1. Kruidenier L, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response (2012) Nature. 488(7411):404-8.
  • 2. SGC website: http://www.thesgc.org/scientists/chemical_probes/GSKJ1

  • GSK-J1_spec.pdf
  • GSK-J1_MSDS.pdf

Products are for research use only. Not for human use.

新闻动态
行业前沿
技术文章
最新产品